Recombinant Human HER2/CD340/ERBB2 Protein
Recombinant Human HER2/CD340/ERBB2 Protein (RP00895-GRP)
Products
Description
Recombinant Human HER2/CD340/ERBB2 Protein is produced by Human cells expression system. The target protein is expressed with sequence (Thr23-Thr652) of human HER2/CD340/ERBB2 (Accession #P04626) fused with an Fc tag at the C-terminus.
Specifications
| Manufacturer | Abclonal Biotechnology |
|---|---|
| Manufacturer Cat# | RP00895 |
| Bio-Activity | Measured by its ability to block anti-ErbB2 mediated inhibition of SK-BR-3 human breast cancer cell proliferation. The ED50 for this effect is typically 20-80 ng/mL in the presence of 0.6 μg/mL goat anti-hErbB2. |
| Alternate Names | Receptor tyrosine-protein kinase erbB-2; Metastatic lymph node gene 19 protein; Proto-oncogene Neu;Tyrosine kinase-type cell surface receptor HER2; ERBB2;MLN19;NGL;TKR1 |
| Reactivity | Human |
| Gene ID | 2064 |
| Swiss Prot | P04626 |
| Storage | -80℃ |